All News about Immuron Ltd ADR
Immuron Receives FDA Approval for Travelan IND Application
December 23, 2022
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
December 22, 2022
Via Benzinga
Immuron Submits IND Application To FDA for Travelan
December 05, 2022
From Immuron Limited
Via GlobeNewswire
Via Benzinga
Via Benzinga
Immuron completes strategic investment in leading gut health biotech Ateria Health
November 16, 2022
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at AusBioInvest
October 26, 2022
From Immuron Limited
Via GlobeNewswire
From Immuron Limited
Via GlobeNewswire
From Immuron Limited
Via GlobeNewswire
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|